AC-082
- Generic Name
- AC-082
First-in-man Study of Single and Multiple Ascending Doses of a New Drug for Neurological Disorders
- First Posted Date
- 2016-03-09
- Last Posted Date
- 2018-07-10
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 128
- Registration Number
- NCT02702648
- Locations
- 🇩🇪
Investigator Site, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath